immune system. 24 In these anatomical reservoirs autonomous viral replication can occur, and systemic viral reseeding could emerge.
It has been observed that virus evolution and trafficking between tissues compartments continue in patients with undetectable levels of virus in blood. 21 Thus, immunological and/or pharmacological control of this latent HIV reservoir is necessary to effectively manage HIV without cART. For this reason, in recent years, one of the most active areas in HIV research has endeavored to understand the mechanisms involved in the establishment and maintenance of the HIV reservoir.
We will briefly review the most recent advances concerning the establishment and subsequent control of HIV reservoir, with particular emphasis on the main cell populations described as being involved in the maintenance of the HIV reservoir. Although resting memory CD4+ T-cells (Trm) have been the most widely studied, we will focus we will also examine other cell types different from T cells that have been proposed as important harboring of the HIV reservoir. Finally, we will also discuss the wide range of therapeutic strategies used to look for the longed HIV eradication.
| THE ESTABLISHMENT OF HIV RESERVOIR
Soon after it was demonstrated that cART may not be sufficient to completely cure HIV, a seminal study showed that the latent HIV reservoir is established at a very early stage of the disease, just a few days after the initial infection. 25 As a result, treatment during primary HIV-1 infection does not block the establishment of a pool of latently infected resting CD4+ T-cells. 26, 27 Several other studies have confirmed these findings, and have shown that very early cART reduces reservoir size. 25, [28] [29] [30] [31] [32] [33] Interestingly, in a cohort of patients treated soon after infection and who controlled viremia after cART discontinuation (the so-called "post-treatment HIV controllers"), a markedly lower viral reservoir was observed. 31, 32 This suggests an interesting link between the reservoir size and the potential control of HIV infection.
The mechanisms involved in the establishment of HIV latency are not completely understood, and several models have been
proposed. Viral latency could be established through a mechanism in which activated HIV-1-infected CD4+ T-cells revert to a resting state non-permissive for viral gene expression. 34 According to a second model, latency would occur with the direct infection of CD4+ T-cells reverting to a G0 resting memory state. 34 Another model indicates that latency may be established through direct infection of Trm cells. 35 A recent study by Chavez et al has shown that all 3 scenarios could produce latent HIV infection, although the probability of establishing latency could be higher in resting CD4+
T cells, whereas productive infection is more likely to occur in activated cells. 36 Cytokines may be an important factor in the establishment of HIV latency. Immunomodulatory cytokines, such as IL-10 and transforming growth factor-beta, play a key role during the immunosuppressive phase of the immune response, 37,38 and they could contribute to the generation of a pool of long-lived latently infected cells by the reduction of T-cell activation. More recently, it has been demonstrated that IL-2 and IL-7 induce SAMHD1 phosphorylation in primary CD4+ lymphocytes, eliminating SAMHD1 antiviral activity, increasing the infectivity of memory cells, and leading to HIV integration and reservoir replenishment. 39 In addition, these cytokines are able to partially reactivate the reservoir from central memory CD4+ T-cells through homeostatic proliferation, although they are unable to reduce the reservoir size. In recent years, it has become evident that the mechanisms that promote and sustain the latent infection must be understood. 
| Stem cell-like memory T (Tscm) cells
Tscm cell subset was first described in a murine model as a CD8+
T-cell subset with enhanced self-renewal and multipotency features able to differentiate into all types of T-cell subpopulations. 67 A possible route was defined by which Tscm CD8+ T-cells are generated through 
| T follicular helper (Tfh) and peripheral Tfh cells
T follicular helper cells (Tfh) are a distinct memory T-cell subset (CD45RO + CXCR5+) involved in B-cell development and antibody production.
77,78
Tfh are a heterogeneous population with subspecializations and distinct microenvironmental localizations in secondary lymphoid organs. 79 Although expression of CXCR5 is indispensable for Tfh to enter the B cell follicle, expression of CCR7 could also play a role in helping B cells efficiently produce specific antibodies. 80 Also, it has been described that the costimulatory molecule ICOS taking into account the low CCR5 expression in Tfh cells described by Schaerli et al. 77 On the other hand, the increased proliferation capacity observed in this cell population 92 suggests the participation of the homeostatic proliferation as a mechanism to maintain and expand the infection of Tfh cells. 133 Overall, the most important contribution of DCs to HIV reservoir seems to be the ability to transfer HIV to antigen-specific CD4+ T cells. [134] [135] [136] This seems to be associated to the induction of an important down- HIV in vivo. 140 In addition, these HIV-immunocomplexes on FDCs have the ability to cause infection of susceptible target cells, 141 and it was observed that this FDC-trapped HIV was replication competent. 142 Smith et al showed that HIV-immunocomplex on human FDCs retained in vitro infectivity for at least 25 days, 143 suggesting that FDCs could serve as a long-term source of replication-competent virus. Even, a modeling approach suggests that these FDCs could represent the main source of the low-level viremia when HIV is below the limit of detection. 144 
| Monocytes and macrophages

| Megakaryocytes and platelets
It has been proposed that megakaryocytes and platelets could also play a role in the infection and persistence of HIV. Some studies have described productive HIV infection in megakaryocytes, [145] [146] [147] which seems to be associated with the expression in these cells of the CD4 receptor able to bind HIV. 148 A later study showed that both CCR5 and CXCR4 HIV isolates are able to infect megakaryocytes, 149 although only mature megakaryocytic cells seem to be susceptible to HIV infection. 150 However, it has been observed the induction of apoptosis by HIV gp120, which could limit the potential to establish a latent reservoir in these cells. 151, 152 Similar to megakaryocytes, it has been observed endocytic vacuoles containing HIV particles close to the plasma membrane in platelets. In this internalization process seems to be involved the DC-SIGN receptor. 153 Remarkably, a significant level of HIV has been associated to platelets during all stages of HIV infection. 154 In relation to the "kill" within the "shock and kill" strategy, greater attention has been given to the design of immunotherapeutic interventions in combination with LRAs to purge the HIV reservoir. These approaches include enhancing anti-HIV T-cell immunity and innate immunity and/or virus-specific neutralizing antibodies. 186 Given the relevance of virus-specific CD8+ T-cells in the infected cells elimination and in the virus replication control, stimulation of adaptive immune response has been explored in combination with LRAs. In in vitro studies, boosting CTL response before using LRAs to reactivate the latent reservoir showed the ability of CD8+ T-cells to efficiently kill reactivated HIV-infected resting CD4+ T-cells. 187, 188 However, in vivo, the existence of provirus with escape mutations in dominant CD8+ T epitopes might preclude the final elimination of reactivated cells. [189] [190] [191] Also, exhaustion and dysfunction, [192] [193] [194] [195] significant difference in ADCC responses. 206 The authors propose that variable susceptibility to ADCC could be the consequence of the high variability seen in the binding of antibodies to the Env epitopes, which could be associated with high differential expression of the HIV-epitopes. 205, 206 However, in order to be effective, ADCC activity will most likely require a potent reactivation, optimal antigen expression, and high antibody potency. Further investigation into this strategy is thus warranted.
Overall, in spite of some promising data, the inconclusive results produced by the aforementioned strategies indicate that the search for approaches that can effectively target the HIV reservoir must still surmount many barriers. It seems clear that single therapies are unlikely to achieve a functional cure or the complete HIV elimination.
Combined therapies including the improvement of the immune response (innate and/or adaptive) are an important therapeutic alternative with great potential to impact the latent reservoir in vivo. 
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